{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:04:56Z","timestamp":1792757096270,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Noninvasive myocardial imaging modalities, such as cardiac magnetic resonance (CMR), single photon emission computed tomography (SPECT), and Positron emission tomography (PET), are well-established and extensively used to detect cardiac amyloid (CA). The purpose of this study is to directly compare CMR, SPECT, and PET scans in the diagnosis of CA, and to provide evidence for further scientific research and clinical decision-making.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Embase, and Cochrane Library were searched. Studies used CMR, SPECT and\/or PET for the diagnosis of CA were included. Pooled sensitivity, specificity, positive and negative likelihood ratio (LR), diagnostic odds ratio (DOR), their respective 95% confidence intervals (CIs) and the area under the summary receiver operating characteristic (SROC) curve (AUC) were calculated. Quality assessment of included studies was conducted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 31 articles were identified for inclusion in this meta-analysis. The pooled sensitivities of CMR, SPECT and PET were 0.84, 0.98 and 0.78, respectively. Their respective overall specificities were 0.87, 0.92 and 0.95. Subgroup analysis demonstrated that <jats:sup>99m<\/jats:sup>Tc-HMDP manifested the highest sensitivity (0.99). <jats:sup>99m<\/jats:sup>Tc-PYP had the highest specificity (0.95). The AUC values of <jats:sup>99m<\/jats:sup>Tc-DPD, <jats:sup>99m<\/jats:sup>Tc-PYP, <jats:sup>99m<\/jats:sup>Tc-HMDP were 0.89, 0.99, and 0.99, respectively. PET scan with <jats:sup>11<\/jats:sup>C-PIB demonstrated a pooled sensitivity of 0.91 and specificity of 0.97 with an AUC value of 0.98.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our meta-analysis reveals that SEPCT scans present better diagnostic performance for the identification of CA as compared with other two modalities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02292-z","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T13:22:00Z","timestamp":1633612920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhaoye","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"6","key":"2292_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583\u201396.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"2292_CR2","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","volume":"18","author":"A Martinez-Naharro","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018;18(Suppl 2):s30\u20135.","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"2292_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2015141744","volume":"277","author":"M Fontana","year":"2015","unstructured":"Fontana M, Banypersad SM, Treibel TA, Abdel-Gadir A, Maestrini V, Lane T, Gilbertson JA, Hutt DF, Lachmann HJ, Whelan CJ, et al. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology. 2015;277(2):388\u201397.","journal-title":"Radiology"},{"issue":"3","key":"2292_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacbts.2019.02.002","volume":"4","author":"KW Zhang","year":"2019","unstructured":"Zhang KW, Stockerl-Goldstein KE, Lenihan DJ. Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis. JACC Basic Transl Sci. 2019;4(3):438\u201348.","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"2292_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cpcardiol.2017.04.003","volume":"43","author":"S Bhogal","year":"2018","unstructured":"Bhogal S, Ladia V, Sitwala P, Cook E, Bajaj K, Ramu V, Lavie CJ, Paul TK. Cardiac amyloidosis: an updated review with emphasis on diagnosis and future directions. Curr Probl Cardiol. 2018;43(1):10\u201334.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"2292_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","volume":"26","author":"V Singh","year":"2019","unstructured":"Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019;26(1):158\u201373.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"2292_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","volume":"21","author":"S Bokhari","year":"2014","unstructured":"Bokhari S, Shahzad R, Casta\u00f1o A, Maurer MS. Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol. 2014;21(1):175\u201384.","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"2292_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.2214\/AJR.20.22790","volume":"215","author":"M Yang","year":"2020","unstructured":"Yang M, Arsanjani R, Roarke MC. Advanced nuclear medicine and molecular imaging in the diagnosis of cardiomyopathy. AJR Am J Roentgenol. 2020;215(5):1208\u201317.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"2292_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","volume":"2","author":"BA Austin","year":"2009","unstructured":"Austin BA, Tang WH, Rodriguez ER, Tan C, Flamm SD, Taylor DO, Starling RC, Desai MY. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2(12):1369\u201377.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2292_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, Sheppard MN, Poole-Wilson PA, Hawkins PN, Pennell DJ. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111(2):186\u201393.","journal-title":"Circulation"},{"issue":"4","key":"2292_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","volume":"70","author":"A Martinez-Naharro","year":"2017","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70(4):466\u201377.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2292_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","volume":"45","author":"G Treglia","year":"2018","unstructured":"Treglia G, Glaudemans A, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, Ceriani L, Prior JO, Giovanella L, Slart R. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Eur J Nucl Med Mol Imaging. 2018;45(11):1945\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2292_CR13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s12350-019-01935-1","volume":"27","author":"SC Ramsay","year":"2020","unstructured":"Ramsay SC, Cuscaden C. The current status of quantitative SPECT\/CT in the assessment of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020;27(5):1464\u20138.","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"2292_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2967\/jnumed.120.245381","volume":"61","author":"A Masri","year":"2020","unstructured":"Masri A, Bukhari S, Eisele YS, Soman P. Molecular imaging of cardiac amyloidosis. J Nucl Med. 2020;61(7):965\u201370.","journal-title":"J Nucl Med"},{"issue":"9","key":"2292_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, Moore SC, Falk RH. Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41(9):1652\u201362.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2292_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12350-018-1260-5","volume":"27","author":"R Minamimoto","year":"2020","unstructured":"Minamimoto R, Awaya T, Iwama K, Hotta M, Nakajima K, Hirai R, Okazaki O, Hiroi Y. Significance of (11)C-PIB PET\/CT in cardiac amyloidosis compared with (99m)Tc-aprotinin scintigraphy: a pilot study. J Nucl Cardiol. 2020;27(1):202\u20139.","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"2292_CR17","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","volume":"57","author":"WP Law","year":"2016","unstructured":"Law WP, Wang WY, Moore PT, Mollee PN, Ng AC. Cardiac amyloid imaging with 18F-Florbetaben PET: a pilot study. J Nucl Med. 2016;57(11):1733\u20139.","journal-title":"J Nucl Med"},{"issue":"7","key":"2292_CR18","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","volume":"46","author":"M Kircher","year":"2019","unstructured":"Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kort\u00fcm KM, St\u00f6rk S, Buck AK, Reiter T, Bauer WR, et al. Detection of cardiac amyloidosis with 18F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46(7):1407\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2292_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12872-016-0311-6","volume":"16","author":"L Zhao","year":"2016","unstructured":"Zhao L, Tian Z, Fang Q. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016;16:129.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"2292_CR20","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/jmri.27459","volume":"53","author":"TKM Wang","year":"2020","unstructured":"Wang TKM, Brizneda MV, Kwon DH, Popovic ZB, Flamm SD, Hanna M, Griffin BP, Xu B. Reference ranges, diagnostic and prognostic utility of native T1 mapping and extracellular volume for cardiac amyloidosis: a meta-analysis. J Magn Reson Imaging: JMRI. 2020;53(5):1458\u201368.","journal-title":"J Magn Reson Imaging: JMRI."},{"issue":"6","key":"2292_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","volume":"13","author":"JA Pan","year":"2020","unstructured":"Pan JA, Kerwin MJ, Salerno M. Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc Imaging. 2020;13(6):1299\u2013310.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2292_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","volume":"27","author":"YJ Kim","year":"2020","unstructured":"Kim YJ, Ha S, Kim YI. Cardiac amyloidosis imaging with amyloid positron emission tomography: a systematic review and meta-analysis. J Nucl Cardiol. 2020;27(1):123\u201332.","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"2292_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jjcc.2020.07.003","volume":"76","author":"SH Kim","year":"2020","unstructured":"Kim SH, Kim YS, Kim SJ. Diagnostic performance of PET for detection of cardiac amyloidosis: a systematic review and meta-analysis. J Cardiol. 2020;76(6):618\u201325.","journal-title":"J Cardiol"},{"issue":"5","key":"2292_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (London, England). 2010;8(5):336\u201341.","journal-title":"Int J Surg (London, England)"},{"issue":"11","key":"2292_CR25","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1373\/clinchem.2012.182568","volume":"58","author":"JB Reitsma","year":"2012","unstructured":"Reitsma JB, Moons KG, Bossuyt PM, Linnet K. Systematic reviews of studies quantifying the accuracy of diagnostic tests and markers. Clin Chem. 2012;58(11):1534\u201345.","journal-title":"Clin Chem"},{"key":"2292_CR26","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2292_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882\u201393.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2292_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12350-019-01754-4","volume":"27","author":"S Cuddy","year":"2020","unstructured":"Cuddy S, Dorbala S, Di Carli MF. Imaging of cardiac amyloidosis: will this become a unique application for dual-isotope imaging? J Nucl Cardiol. 2020;27(1):38\u201340.","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"2292_CR29","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1148\/rg.2020200068","volume":"40","author":"M Hotta","year":"2020","unstructured":"Hotta M, Minamimoto R, Awaya T, Hiroe M, Okazaki O, Hiroi Y. Radionuclide imaging of cardiac amyloidosis and sarcoidosis: roles and characteristics of various tracers. Radiographics. 2020;40(7):2029\u201341.","journal-title":"Radiographics"},{"issue":"11","key":"2292_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/mcp.2011.0296","volume":"86","author":"AM From","year":"2011","unstructured":"From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clin Proc. 2011;86(11):1095\u2013102.","journal-title":"Mayo Clin Proc"},{"issue":"12 Suppl 3","key":"2292_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","volume":"84","author":"JP Donnelly","year":"2017","unstructured":"Donnelly JP, Hanna M. Cardiac amyloidosis: an update on diagnosis and treatment. Clevel Clin J Med. 2017;84(12 Suppl 3):12\u201326.","journal-title":"Clevel Clin J Med"},{"issue":"1","key":"2292_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","volume":"28","author":"OK Siddiqi","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018;28(1):10\u201321.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2292_CR33","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.4084\/mjhid.2012.037","volume":"4","author":"U Barbero","year":"2012","unstructured":"Barbero U, Destefanis P, Pozzi R, Longo F, Piga A. Exercise stress echocardiography with tissue Doppler imaging (TDI) detects early systolic dysfunction in Beta-thalassemia major patients without cardiac iron overload. Mediterr J Hematol Infect Dis. 2012;4(1):12037.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"2292_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12872-018-0952-8","volume":"18","author":"P Kyriakou","year":"2018","unstructured":"Kyriakou P, Mouselimis D, Tsarouchas A, Rigopoulos A, Bakogiannis C, Noutsias M, Vassilikos V. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc Disord. 2018;18(1):221.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"2292_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cardfail.2017.12.006","volume":"24","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Ruberg FL, Weinsaft JW. More than meets the eye: time for a new imaging paradigm to test for cardiac amyloidosis. J Card Fail. 2018;24(2):87\u20139.","journal-title":"J Card Fail"},{"issue":"10","key":"2292_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51(10):1022\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2292_CR37","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","volume":"27","author":"BW Sperry","year":"2020","unstructured":"Sperry BW, Burgett E, Bybee KA, McGhie AI, O\u2019Keefe JH, Saeed IM, Thompson RC, Bateman TM. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT\/CT. J Nucl Cardiol. 2020;27(5):1802\u20137.","journal-title":"J Nucl Cardiol"},{"issue":"10","key":"2292_CR38","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","volume":"47","author":"N Malka","year":"2020","unstructured":"Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, et al. Extracardiac soft tissue uptake, evidenced on early (99m)Tc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47(10):2396\u2013406.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"2292_CR39","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/jcm9113446","volume":"9","author":"T Wollenweber","year":"2020","unstructured":"Wollenweber T, Rettl R, Kretschmer-Chott E, Rasul S, Kulterer O, Rainer E, Raidl M, Schaffarich MP, Matschitsch S, Stadler M, et al. In vivo quantification of myocardial amyloid deposits in patients with suspected transthyretin-related amyloidosis (ATTR). J Clin Med. 2020;9(11):3446.","journal-title":"J Clin Med"},{"key":"2292_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02425-5","author":"LX Zhang","year":"2020","unstructured":"Zhang LX, Martineau P, Finnerty V, Giraldeau G, Parent MC, Harel F, Pelletier-Galarneau M. Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis. J Nucl Cardiol. 2020. https:\/\/doi.org\/10.1007\/s12350-020-02425-5.","journal-title":"J Nucl Cardiol."},{"issue":"6","key":"2292_CR41","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","volume":"13","author":"S Rosengren","year":"2020","unstructured":"Rosengren S, Skibsted Clemmensen T, Tolbod L, Granstam SO, Eiskj\u00e6r H, Wikstr\u00f6m G, Vedin O, Kero T, Lubberink M, Harms HJ, et al. Diagnostic accuracy of [(11)C]PIB positron emission tomography for detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2020;13(6):1337\u201347.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2292_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02363-2","author":"M Papathanasiou","year":"2020","unstructured":"Papathanasiou M, Kessler L, Carpinteiro A, Hagenacker T, Nensa F, Umutlu L, Forsting M, Brainman A, Kleinschnitz C, Antoch G, et al. (18)F-flutemetamol positron emission tomography in cardiac amyloidosis. J Nucl Cardiol. 2020. https:\/\/doi.org\/10.1007\/s12350-020-02363-2.","journal-title":"J Nucl Cardiol."},{"issue":"7","key":"2292_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","volume":"17","author":"A Martinez-Naharro","year":"2020","unstructured":"Martinez-Naharro A, Baksi AJ, Hawkins PN, Fontana M. Diagnostic imaging of cardiac amyloidosis. Nat Rev Cardiol. 2020;17(7):413\u201326.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2292_CR44","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s12350-019-01885-8","volume":"28","author":"M Abulizi","year":"2019","unstructured":"Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Isra\u00ebl JM, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, et al. (18)F-sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol. 2019;28(4):1586\u201395.","journal-title":"J Nucl Cardiol."},{"issue":"6","key":"2292_CR45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10554-014-0436-6","volume":"30","author":"GD Aquaro","year":"2014","unstructured":"Aquaro GD, Pugliese NR, Perfetto F, Cappelli F, Barison A, Masci PG, Passino C, Emdin M. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis. Int J Cardiovasc Imaging. 2014;30(6):1105\u201315.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"2292_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12350-020-02328-5","volume":"28","author":"T Asif","year":"2020","unstructured":"Asif T, Gomez J, Singh V, Doukky R, Nedeltcheva A, Malhotra S. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. J Nucl Cardiol. 2020;28(1):104\u201311.","journal-title":"J Nucl Cardiol."},{"issue":"4","key":"2292_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s12350-019-01868-9","volume":"27","author":"T Awaya","year":"2020","unstructured":"Awaya T, Minamimoto R, Iwama K, Kubota S, Hotta M, Hirai R, Yamamoto M, Okazaki O, Hara H, Hiroi Y, et al. Performance of (99m)Tc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy. J Nucl Cardiol. 2020;27(4):1145\u201353.","journal-title":"J Nucl Cardiol"},{"issue":"1 Pt 1","key":"2292_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, et al. Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):69\u201380.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2292_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12471-017-1046-4","volume":"26","author":"M Baroni","year":"2018","unstructured":"Baroni M, Nava S, Quattrocchi G, Milazzo A, Giannattasio C, Roghi A, Pedrotti P. Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor. Neth Heart J. 2018;26(1):34\u201340.","journal-title":"Neth Heart J"},{"key":"2292_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02274-2","author":"D Bellevre","year":"2020","unstructured":"Bellevre D, Bailliez A, Delelis F, Blaire T, Agostini D, Mouquet F, Mar\u00e9chaux S, Manrique A. Quantitation of myocardial (99m)Tc-HMDP uptake with new SPECT\/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: ready for clinical use? J Nucl Cardiol. 2020;. https:\/\/doi.org\/10.1007\/s12350-020-02274-2.","journal-title":"J Nucl Cardiol."},{"issue":"9","key":"2292_CR51","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/ehjci\/jew101","volume":"17","author":"S Bhatti","year":"2016","unstructured":"Bhatti S, Watts E, Syed F, Vallurupalli S, Pandey T, Jambekar K, Mazur W, Hakeem A. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2016;17(9):970\u20137.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"2292_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","volume":"26","author":"F Cappelli","year":"2019","unstructured":"Cappelli F, Gallini C, Di Mario C, Costanzo EN, Vaggelli L, Tutino F, Ciaccio A, Bartolini S, Angelotti P, Frusconi S, et al. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2019;26(2):497\u2013504.","journal-title":"J Nucl Cardiol"},{"issue":"3","key":"2292_CR53","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N, Katoh N, Oguchi K, Yoshinaga T, Yazaki M, Sekijima Y. Visualization of multiple organ amyloid involvement in systemic amyloidosis using (11)C-PiB PET imaging. Eur J Nucl Med Mol Imaging. 2018;45(3):452\u201361.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2292_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12350-019-01831-8","volume":"27","author":"KR Flaherty","year":"2020","unstructured":"Flaherty KR, Morgenstern R, Pozniakoff T, DeLuca A, Castano A, Maurer MS, Bokhari S. (99m)Technetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020;27(2):371\u201380.","journal-title":"J Nucl Cardiol"},{"key":"2292_CR55","doi-asserted-by":"crossref","unstructured":"Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, Morini S, Bartolini S, Farsetti S, Di Mario C, et al. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. J Nucl Cardiol. 2019.","DOI":"10.1007\/s12350-019-01643-w"},{"issue":"24","key":"2292_CR56","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404\u201312.","journal-title":"Circulation"},{"issue":"4","key":"2292_CR57","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488\u201397.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"2292_CR58","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","volume":"46","author":"M Kircher","year":"2019","unstructured":"Kircher M, Ihne S, Brumberg J, Morbach C, Knop S, Kort\u00fcm KM, St\u00f6rk S, Buck AK, Reiter T, Bauer WR, et al. Detection of cardiac amyloidosis with (18)F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46(7):1407\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2292_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"SP Lee","year":"2015","unstructured":"Lee SP, Lee ES, Choi H, Im HJ, Koh Y, Lee MH, Kwon JH, Paeng JC, Kim HK, Cheon GJ, et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging. 2015;8(1):50\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2292_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12350-019-01675-2","volume":"28","author":"P Martineau","year":"2019","unstructured":"Martineau P, Finnerty V, Giraldeau G, Authier S, Harel F, Pelletier-Galarneau M. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis. J Nucl Cardiol. 2019;28(1):209\u201318.","journal-title":"J Nucl Cardiol."},{"issue":"2","key":"2292_CR61","doi-asserted-by":"publisher","first-page":"e010249","DOI":"10.1161\/CIRCIMAGING.119.010249","volume":"13","author":"A Masri","year":"2020","unstructured":"Masri A, Bukhari S, Ahmad S, Nieves R, Eisele YS, Follansbee W, Brownell A, Wong TC, Schelbert E, Soman P. Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging. 2020;13(2):e010249.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"2292_CR62","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.hlc.2016.12.017","volume":"26","author":"PT Moore","year":"2017","unstructured":"Moore PT, Burrage MK, Mackenzie E, Law WP, Korczyk D, Mollee P. The utility of (99m)Tc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience. Heart Lung Circ. 2017;26(11):1183\u201390.","journal-title":"Heart Lung Circ"},{"issue":"Suppl 1","key":"2292_CR63","first-page":"42","volume":"18","author":"V Papantoniou","year":"2015","unstructured":"Papantoniou V, Valsamaki P, Kastritis S, Tsiouris S, Delichas Z, Papantoniou Y, Tsiouma M, Athanasoulis T, Fotopoulos A, Dimopoulos MA. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy. Hell J Nucl Med. 2015;18(Suppl 1):42\u201350.","journal-title":"Hell J Nucl Med"},{"issue":"6","key":"2292_CR64","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","volume":"14","author":"TJ Poterucha","year":"2020","unstructured":"Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, et al. Diagnosing transthyretin cardiac amyloidosis by technetium 99m pyrophosphate: a test in evolution. JACC Cardiovasc Imaging. 2020;14(6):1221\u201331.","journal-title":"JACC Cardiovasc Imaging."},{"issue":"6","key":"2292_CR65","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","volume":"4","author":"C Rapezzi","year":"2011","unstructured":"Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, Longhi S, Lorenzini M, Reggiani LB, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4(6):659\u201370.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"2292_CR66","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s12350-020-02205-1","volume":"27","author":"C R\u00e9gis","year":"2020","unstructured":"R\u00e9gis C, Harel F, Martineau P, Gr\u00e9goire J, Abikhzer G, Juneau D, Pelletier-Galarneau M. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: comparison of quantitative and semi-quantitative approaches. J Nucl Cardiol. 2020;27(5):1808\u201315.","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"2292_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","volume":"7","author":"JA White","year":"2014","unstructured":"White JA, Kim HW, Shah D, Fine N, Kim KY, Wendell DC, Al-Jaroudi W, Parker M, Patel M, Gwadry-Sridhar F, et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):143\u201356.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02292-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02292-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02292-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T14:13:09Z","timestamp":1633615989000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02292-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2292"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02292-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"13 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}